The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Chiral drugs: comparison of the pharmacokinetics of [ 11 C] d-threo and l-threo -methylphenidate in the human and baboon brain
Open accessAbstract
Methylphenidate (Ritalin) is the most commonly prescribed psychoactive medication for children in the US where it is used for the treatment of attention deficit hyperactivity disorder. Methylphenidate is marketed as a racemic mixture of the d-threo and l-threo enantiomers. It is believed that the d enantiomer is responsible for the therapeutic effect of methylphenidate. In this study we labeled the individual enantiomers with carbon-11 and compared their binding and pharmacokinetics in the human and baboon brain. Microdialysis studies in the rat were performed to compare their potency in elevating striatal dopamine concentration. Positron emission tomographic (PET) studies with [11C]d-threo-methylphenidate ([11C]d-threo-MP) demonstrated highest regional uptake in basal ganglia. In contrast, [11C]l-threo-methylphenidate ([11C]l-threo-MP) displayed similar uptakes in all brain regions. The ratios of distribution volumes at the steady-state for the basal ganglia to cerebellum (DVBG/DVCB) ranged from 2.2 to 3.3 for [11C]d-threo-MP in baboon and human, and only 1.1 for [11C]l-threo-MP. Pretreatment with unlabeled methylphenidate (0.5 mg/kg) or GBR12909 (1.5 mg/kg) markedly reduced the striatal but not the cerebellar uptake of [11C]d-threo-MP, whereas there was no effect on DVBG/DVCB for [11C]l-threo-MP. In the rat, d-threo-MP increased extracellular dopamine concentration by 650% whereas l-threo-MP did not affect dopamine levels. These results indicate that pharmacological specificity of MP resides entirely in the d-threo isomer and directly show that binding of the l-isomer in human brain is mostly nonspecific.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180 · cited 1×
“However, it has been shown that d-threo-MP is more potent in the induction of locomotor activity and has a higher affinity for the dopamine transporter than l-threo-MP (Barkely 1977; Schweri et al. 1985; Patrick et al. 1987; Ritz et al. 1987; Pan et al. 1994).”
BackgroundLogan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479
Self-citationHyperactive Boys Almost Grown Up: I. Psychiatric Status
Gittelman, R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330017002 · Cited by 977
A REVIEW OF STIMULANT DRUG RESEARCH WITH HYPERACTIVE CHILDREN
Barkley, R. A. (1977) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1977.tb00425.x · Cited by 541 · cited 1×
“Attention deficit hyperactivity disorder (ADHD), which is estimated to affect more than 2 million children (or 3‐5%), has become America’s no. 1 childhood psychiatric disorder ( Barkley 1977 ).”
BackgroundImaging endogenous dopamine competition with [11C]raclopride in the human brain
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., et al. (1994) · Synapse · doi:10.1002/syn.890160402 · Cited by 379
Self-citationZetterström, T., Sharp, T., Collin, A. K., & Ungerstedt, U. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90110-0 · Cited by 378 · cited 1×
“The mechanism(s) which make methylphenidate work for ADHD patients is still unclear, though it has been suggested that the stimulant appears to increase the level of extracellular dopamine in the frontal lobe of the brain ( Zetterstrom et al. 1988; Butcher et al. 1991; Volkow et al. 1994), where it regulates attention…”
BackgroundThe dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action
Andersen, P. H. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90363-4 · Cited by 346
FERRIS, R. M., TANG, F. L. M., & MAXWELL, R. A. (1972) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29222-9 · Cited by 301
Dopamine transporters decrease with age.
Volkow, N. D., Ding, Y., Fowler, J. S., Wang, G., Logan, J., Gatley, S. J., Hitzemann, R., Smith, G., Fields, S. D., & Gur, R. C. (1996) · PubMed · Cited by 262
Self-citationPET evaluation of the dopamine system of the human brain.
Volkow, N. D., Fowler, J., Sj, G., Logan, J., Wang, G., Ding, Y., & Dewey, S. L. (1996) · PubMed · Cited by 251
Self-citation
Cited by
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“…NE to bind to their respective transporters (i.e., the DAT or NET) or to DA or NE receptors, as evidenced by reductions in ligand binding in PET and SPECT studies (Ding et al., 1997; Dresel et al., 1999; Gatley et al., 1999; Nikolaus et al., 2005, Nikolaus et al., 2007, 2011; Volkow et al., 1999a).”
Methylphenidate: Its Pharmacology and Uses
CHALLMAN, T. D., & LIPSKY, J. J. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64618-1 · Cited by 553
Volkow, N. D., Wang, G.-J., Fowler, J. S., & Ding, Y.-S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.006 · Cited by 368
Self-citationAttention-Deficit/Hyperactivity Disorder and Attention Networks
Bush, G. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.120 · Cited by 358
“Pioneering PET work by Volkow and colleagues has showed the specific activity of MPH’s d-enantiomer in the basal ganglia (Ding et al, 1997), that oral MPH blocks the DAT with a time course matching behavioral effects (Volkow et al, 1998), and that MPH increases extracellular dopamine in the…”
Background
Metadata
- Authors
- Ding, Y.-S., Fowler, J. S., Volkow, N. D., Dewey, S. L., Wang, G.-J., Logan, J., Gatley, S. J., & Pappas, N.
- Affiliations
- Brookhaven National Laboratory (US)
- Venue
- Psychopharmacology
- Published
- 1997-05-15
- Volume
- 131
- Issue
- 1
- Pages
- 71-78
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1990494131
- Cited by
- 157
- References
- 31
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 11
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- public-domain
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, public-domain)
- Funders
- National Institutes of Health (2r01ns015380-27, 5p01ns015638-15)
- National Institute on Drug Abuse (DA-06278, R01DA006278)
- National Institute of Neurological Disorders and Stroke (NS15638, NS 15380)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- methylphenidate, enantiomers, chiral drugs, pharmacokinetics, brain distribution, striatal dopamine, basal ganglia, cerebellum, GBR 12909, attention deficit hyperactivity disorder, PET radiotracer, microdialysis, baboon brain, human brain
- MeSH terms
- Aged, Animals, Brain, Female, Humans, Male, Methylphenidate, Middle Aged, Papio, Radioligand Assay, Stereoisomerism, Tomography, Emission-Computed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chiral drugs: comparison of the pharmacokinetics of [ 11 C] d-threo and l-threo -methylphenidate in the human and baboon brain. https://app.cochat.ai/papers/10.1007/s002130050267
- The paper
- Ding, Y.-S., Fowler, J. S., Volkow, N. D., Dewey, S. L., Wang, G.-J., Logan, J., Gatley, S. J., & Pappas, N. (1997). Chiral drugs: comparison of the pharmacokinetics of [ 11 C] d-threo and l-threo -methylphenidate in the human and baboon brain. Psychopharmacology. https://doi.org/10.1007/s002130050267
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.